Shineco, Inc.

Equities

TYHT

US8245674085

Food Processing

Market Closed - Nasdaq 01:30:00 16/07/2024 am IST After market 05:29:55 am
0.98 USD +16.60% Intraday chart for Shineco, Inc. 1.14 +16.33%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Health Care Up as Momentum Builds -- Health Care Roundup DJ
Shanchun Huang Engages in Discussions with Shineco CI
Shineco Announces Public Equity Offering -- Shares Plunge After Hours MT
Fuzhou Meida Health Management Co., Ltd. Entered into Distribution Agreements with Four Distributors, Harbin Liaotongtang Chinese Medicine and Health Research Institute, Three Minutes Information Service Co., Hangzhou Misimao Science and Technology Co., Ltd., and Wu Qiang CI
Shineco, Inc.'s Subsidiary, Fuzhou Meida Health Management Co., Ltd. Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food Beverage CI
Top Premarket Decliners MT
Shineco, Inc. announced that it expects to receive $7 million in funding CI
Shineco, Inc. signed a letter of intent to acquire 80% stake in Beijing Oriental Meitong Technology Co., Ltd. for $20 million. CI
Shineco, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Shineco Regains Compliance With Nasdaq Listing Rule MT
Top Premarket Gainers MT
Shineco, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Shineco, Inc. Announces the Appointment of Two New Executive Officers CI
Shineco, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Shineco, Inc. Opens Healthy Food Restaurant with Focus on Advanced Nutrition CI
Shineco Plans to Boost R&D on Medical Applications of Silk Protein; Shares Rise MT
Shineco, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Shineco, Inc. completed the acquisition of 71.42% stake in Dream Partner Limited for $17.3 million. CI
Shineco Unit's Cardiac Test Receives Regulatory Approval in China MT
Shineco, Inc.'S Subsidiary, Changzhou Biowin Pharmaceutical Co., Ltd., Receives Marketing Approval from China's Regulatory Body for Its Cardiac 5 Minute Test CI
Shineco, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Shineco, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Shineco, Inc. signed a letter of intent to acquire 80% stake in Dream Partner Limited for $40 million. CI
Shineco Affiliate Granted Patent, FDA Marketing Approval for Stool Sample Collecting Device; Shares Jump MT
Shineco, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Chart Shineco, Inc.
More charts
Shineco Inc is a holding company. The Company provides health and well-being focused plant-based products by using its subsidiaries' and variable interest entities' vertically and horizontally integrated production, distribution and sales channels. The Company operates through three segments. Developing, producing and distributing innovative rapid diagnostic products and related medical devices for the most common diseases (Rapid Diagnostic and Other Products) :This segment is conducted through Biowin, which specializes in the development, production and distribution of innovative rapid diagnostic products and related medical devices for the most common diseases; Producing, processing and distribution of agricultural products, such as silk and silk fabrics as well as fresh fruit s (Other agricultural products): This segment is conducted through Wintus, which specializes in producing, processing and distribution of agricultural products, such as silk and silk fabrics as well as tra
More about the company
  1. Stock Market
  2. Equities
  3. TYHT Stock
  4. News Shineco, Inc.
  5. Shineco Announces Public Equity Offering -- Shares Plunge After Hours